F11R and Miyoshi myopathy: Stiff and colleagues97 recently demonstrated that in vitro exposure of MM cells to HDAC-I increased their expression of JAM-1, and dual treatment with RV led to the potentiation of MM cell killing both in vitro and in murine models in vivo.